Clinical Trial Update: DOAC Versus VKA in Patients With Non-high-risk APS : Prospective Cohort Study

View source ↗

Summary

This clinical trial update describes a prospective cohort study comparing direct oral anticoagulants (DOACs) to vitamin K antagonists (VKAs) in patients with no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome

Drugs mentioned

• Eliquis (apixaban)
• Pradaxa (dabigatran etexilate)
• Savaysa (edoxaban)
• Warfarin (warfarin)
• Xarelto (rivaroxaban)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Antiphospholipid Syndrome (APS), Cohort Study | Status: NOT_YET_RECRUITING